Ann: Licencing Deal Expands Noxopharm Drug Opportunities, page-7

Nice announcement but subject to trials and approvals and miles away from actually meaning anything. I get the sense they were desperate to try and announce something after the embarrassment of the grant announcement.

After an early learning experience back in the day, at the first sign of incompetence or mismanagement or an event that really leads me to question managements capability, I exit my position.

Something seems very off with the events of the last few days. I exited on opening and wish all the existing holders the best for the future.

Regards.